Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

Testosterone reduces key molecules needed for early pregnancy in rats.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

A young Saudi girl with uncontrolled type 1 diabetes and hypothyroidism had two rare conditions, Mauriac syndrome and Van Wyk–Grumbach syndrome.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Hairless protein is crucial for healthy skin and hair, and its malfunction can cause hair loss.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The Hairless gene is crucial for healthy skin and hair growth.

Oestrogens are key for bone growth during puberty in both boys and girls.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.